Characterisation and assessment of insomnia

Dieter Riemann (Freiburg, Germany)

Source: Sleep and Breathing Conference 2017
Number: 62

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dieter Riemann (Freiburg, Germany). Characterisation and assessment of insomnia. Sleep and Breathing Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management strategies in insomnia
Source: Sleep and Breathing Conference 2017
Year: 2017

Assessment of quality of life, anxiety and depression in patients with chronic cough
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Validation of the four –variable screening tool in a European population for assessing obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013

Characterisation of a paediatric population referred for a dysfunctional breathing assessment
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Comparison of two biomarkers to assess severity of pediatric sleep disordered breathing
Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children
Year: 2017

Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients
Source: Eur Respir J 2016; 47:1668-1679
Year: 2016



Variability of OSA severity classification between two multiple-night sleep studies
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Chronic insomnia as a risk to somatic and mental health: do the different types of insomnia symptoms make a difference?
Source: Sleep and Breathing Conference 2021
Year: 2021


Impact of cough on insomnia and sleep quality in bronchiectasis
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Techniques for predicting outcome of therapeutic interventions in respiratory disorders during sleep
Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep
Year: 2007



Assessment and management of OSA patients with cognitive dysfunctions
Source: Sleep and Breathing Conference 2021
Year: 2021


Accurate estimation of intermittent asthma classified on the basis of subjective symptoms
Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases
Year: 2010


Effects of pharmacological treatment on residual sleepiness and cognitive functions in OSA patients
Source: Sleep and Breathing Conference 2021
Year: 2021


Real-time symptom monitoring of dyspnea via ecological momentary assessment
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018


Comparison of different criteria for the diagnosis of position and REM related obstructive sleep apnea syndrome and the value for determination of prognosis
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016

Treatment of comorbid insomnia disorder: implications for somatic and mental health
Source: Sleep and Breathing Conference 2021
Year: 2021


Prevalence of anxiety disorder and depression in newly diagnosed obstructive sleep apnea patients
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016


Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018